3rd Quarter - Report
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. for HEREDITARY HEMORRHAGIC TELANGIECTASIA FOUNDATION
Income
$10,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Defense DEF
H.R. 9495/S Unnumbered, FY 2027 Defense Appropriations Act, Peer Reviewed Medical Research Program designation for Hereditary Hemorrhagic Telangiectasia (HHT)
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARK VIETH | — |
Health Issues HCR
H.R. 9495/S. Unnumbered, FY 2027 Defense Appropriations Act, Peer Reviewed Medical Research Program designation for Hereditary Hemorrhagic Telangiectasia (HHT); H.R. 9260/S. Unnumbered, FY 2027 Labor-HHS-Education Act, Funding for National HHT Center of Excellence Program
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARK VIETH | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.